Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ Phase 3 trial of daridorexant in South Korea met both…
Aurobindo Pharma subsidiary launches generic of cancer drug
Aurobindo Pharma subsidiary Eugia Pharma Specialities has launched Pomalidomide Capsules, in different strengths, in the U.S. market. Eugia was one of the first-to-file (FTF) ANDA applicants for the product and will manufacture the product, which…
AbbVie: The Only Big Pharma Stock I'd Consider a Buy-and-Never-Sell
There were times when investors may have worried about hanging onto AbbVie (ABBV 0.39%) stock. A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira. Granted, it was the top-selling drug in the world at…
NATCO Pharma launches generic blood cancer treatment medicine in U.S.
NATCO Pharma on Tuesday announced the launch of generic Pomalidomide capsules indicated for treatment of adult patients with blood and bone marrow cancer in the U.S. market in partnership with Breckenridge Pharmaceutical, Inc. Pomalidomide capsule…
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Strong-Buy at Jefferies Financial Group
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by investment analysts at Jefferies Financial Group to a 'strong-buy' rating in a note issued to investors on Tuesday, Marketbeat Ratings reports. Several other equities research analysts…
Over 30 stocks including Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla, Juniper Hotels will hog limelight
Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company's Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5…
Marjorie Taylor Greene warns Trump may be 'reason' Texas Senate seat flips
Former Republican Representative Marjorie Taylor Greene of Georgia warned that President Donald Trump could be the 'real reason' the Texas Senate seat flips blue in November. Greene, a former staunch MAGA supporter and ally of Trump, has broken…
Furoscix Growth Vs. Tyvaso Royalties: Assessing MannKind's Future (NASDAQ:MNKD)
MannKind Corporation faces strategic risk after United Therapeutics announced plans for a soft-mist treprostinil inhaler, threatening Tyvaso DPI royalties. MNKD's FY25 revenue grew 22% to $349M, driven by product expansion, royalties, and the…
West Asia conflict: Drugmakers brace for export impact, if war is prolonged
Drugmakers are bracing for the delays and price increases that would hit them if the West Asia conflict, already over five days, stretches into months, say industry experts. Countries and drug companies usually have two-three months inventory to…
Nanalysis Announces Grant of Options and Restricted Share Units
CALGARY, AB, March 4, 2026 /CNW/ - Nanalysis Scientific Corp. (the 'Company' or 'Nanalysis') (TSXV: NSCI) (FRA: 1N1) announces the Company's Board of Directors has granted 1,210,000 restricted share units ('RSUs') and 350,000 stock options…
Stock Market Turbulence: How to Invest Wisely and Safely Right Now
The S&P 500 faced headwinds on occasion over the past three years, but it still offered investors a solid path upward, gaining 78%. This happened amid optimism about the growth potential of artificial intelligence (AI) stocks as well as optimism…
Kala Bio Launches AI Platform for Biotech Industry
Massachusetts-based Kala Bio, a clinical-stage biopharmaceutical company, is betting it can turn its own secure AI needs into a new infrastructure business. The company on Wednesday unveiled plans to build a biotech-focused, on-premises AI…
Trump's Prescription Drugs Policy Has Worked
Let's bank the win rather than let Big Pharma bankroll a win for themselves. Heading into this year's midterms, Republicans are jittery. There is particular concern that Democrats could hold over our collective heads the failure to extend…
Ronde van Brugge men past winners
Juan Sebastian Molano (Col) UAE Team Emirates-XRG Jasper Philipsen (Bel) Alpecin-Deceuninck Jasper Philipsen (Bel) Alpecin-Deceuninck Tim Merlier (Bel) Alpecin-Fenix Sam Bennett (IRL) Deceuninck-QuickStep Yves Lampaert (Bel) Deceuninck-QuickStep…
Novo Nordisk Finally Catches Bid After FDA Warns Telehealth Companies
Novo Nordisk shares in Copenhagen finally caught a bid after the U.S. Food and Drug Administration issued 30 warning letters to telehealth companies for making false and misleading claims regarding compounded GLP-1 products (otherwise known as…
Receive a Daily briefing on Pharma Industry News
Get Started